Bioline Rx Ltdの簿価
Bioline Rx Ltdの簿価 は何ですか。
Bioline Rx Ltdの簿価 は1.71です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
NASDAQのセクタHealth Careにおける簿価 の企業と比べるBioline Rx Ltd
Bioline Rx Ltdは何をしますか。
biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m
Bioline Rx Ltdと類似の簿価
- Nextdoorの簿価 は1.71です。
- Mesa Royalty Trustの簿価 は1.71です。
- SLC Agricola SAの簿価 は1.71です。
- Cellectis SAの簿価 は1.71です。
- Goldhaven Resourcesの簿価 は1.71です。
- Glorious Sun Enterprisesの簿価 は1.71です。
- Bioline Rx Ltdの簿価 は1.71です。
- S.A.L. Steelの簿価 は1.71です。
- Winfullの簿価 は1.71です。
- LongFin Corpの簿価 は1.71です。
- Skylight Healthの簿価 は1.72です。
- New Fortressの簿価 は1.72です。
- PNE AGの簿価 は1.72です。